1,129
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

LETM1 (leucine zipper-EF-hand-containing transmembrane protein 1) silence reduces the proliferation, invasion, migration and angiogenesis in esophageal squamous cell carcinoma via KIF14 (kinesin family member 14)

, &
Pages 7656-7665 | Received 30 Jul 2021, Accepted 14 Sep 2021, Published online: 04 Oct 2021

References

  • Reichenbach ZW, Murray MG, Saxena R, et al. Clinical and translational advances in esophageal squamous cell carcinoma. Adv Cancer Res. 2019;144:95–135.
  • Yin Z, Cai H, Wang Z, et al. Pseudolaric acid B inhibits proliferation, invasion, and angiogenesis in esophageal squamous cell carcinoma through regulating CD147. Drug Des Devel Ther. 2020;14:4561–4573.
  • He S, Zhang H, Xiao Z, et al. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1). Bioengineered. 2021;12(1):601–614.
  • Li H, Piao L, Xu D, et al. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma. Exp Mol Pathol. 2020;112:104333.
  • Piao L, Yang Z, Feng Y, et al. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma. BMC Cancer. 2019;19(1):898.
  • Piao L, Feng Y, Yang Z, et al. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma. Pathol Res Pract. 2019;215(7):152437.
  • Yang Z, Ni W, Cui C, et al. identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma. Hum Pathol. 2018;81:148–156.
  • Yang Z, Li C, Yan C, et al. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochim Biophys Acta Mol Basis Dis. 1865;181-192:2019.
  • Wang ZZ, Yang J, Jiang BH, et al. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. Int J Oncol. 2018;53:1939–1952.
  • Xu H, Zhao G, Zhang Y, et al. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression. J Exp Clin Cancer Res. 2019;38(1):486.
  • Osako Y, Seki N, Kita Y, et al. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma. Int J Oncol. 2016;49(6):2255–2264.
  • Han BA, Yang XP, Hosseini DK, et al. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma. Sci Rep. 2020;10(1):9735.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
  • Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020;50(1):12–20.
  • Liu X, Zhang M, Ying S, et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. Gastroenterology. 2017;153(1):166–177.
  • Zheng Y, Chen Z, Han Y, et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat Commun. 2020;11(1):6268.
  • Shi Q, Diao Y, Jin F, et al. Antimetastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial mesenchymal transition and angiogenesis. Mol Med Rep. 2018;18:131–138.
  • Zhang J, Luo A, Huang F, et al. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Cancer Lett. 2020;469:390–398.
  • Liu B, Li X, Li C, et al. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling. Bioengineered. 2019;10(1):679–688.
  • Jin X, Zhu Z, Shi Y. Metastasis mechanism and gene/protein expression in gastric cancer with distant organs metastasis. Bull Cancer. 2014;101(1):E1–12.
  • Lin EW, Karakasheva TA, Hicks PD, et al. The tumor microenvironment in esophageal cancer. Oncogene. 2016;35(41):5337–5349.
  • Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis. 2017;20(2):185–204.
  • Zhang Y, Chen L, Cao Y, et al. LETM1 promotes gastric cancer cell proliferation, migration, and invasion via the pi3k/akt signaling pathway. J Gastric Cancer. 2020;20(2):139–151.
  • Xu J, Huang B, Li S, et al. Knockdown of LETM1 inhibits proliferation and metastasis of human renal cell carcinoma cells. Oncol Lett. 2018;16:6377–6382.
  • Huang W, Wang J, Zhang D, et al. Inhibition of KIF14 suppresses tumor cell growth and promotes apoptosis in human glioblastoma. Cell Physiol Biochem. 2015;37(5):1659–1670.
  • Cai Z, Wei Y, Chen S, et al. Screening and identification of key biomarkers in alimentary tract cancers: a bioinformatic analysis. Cancer Biomark. 2020;29(2):221–233.
  • Huang C, Hu CG, Ning ZK, et al. Identification of key genes controlling cancer stem cell characteristics in gastric cancer. World J Gastrointest Surg. 2020;12(11):442–459.
  • Corson TW, Huang A, Tsao MS, et al. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene. 2005;24(30):4741–4753.